Overview Request Sample Pages Request Customization Download PDF
You are viewing: China Infusion Pump Market analysis
Part of: Infusion Pump Market (Global)

The China Infusion Pump Market was valued at $1722.1 Million in 2025 and projected to reach to $2808.1 Million by 2030, representing a compound annual growth rate of 10.3%. China's infusion pump market is positioned for sustained growth through 2030, driven by demographic shifts, healthcare modernization initiatives, and expanding access to advanced medical technologies.

China Infusion Pump Market Trends and Insights

  • This expansion reflects China's accelerating healthcare modernization and rising demand for advanced medical devices across hospitals and outpatient facilities.
  • China's aging population and increasing prevalence of chronic diseases are driving adoption of infusion pump technologies in clinical settings. The infusion pump market in China is benefiting from substantial government healthcare investments and the expansion of hospital infrastructure across urban and rural regions.
  • China's regulatory environment has become increasingly supportive of medical device innovation, enabling faster market entry for both domestic and international manufacturers.
  • Between 2025 and 2030, China is expected to maintain its position as a high-growth market within Asia Pacific, with the 10.3% CAGR significantly outpacing global growth trends..

Key Market Statistics

  • CAGR (2025-2030) 10.3% CAGR
  • Market Size, 2025 ~USD 1722.1 Million
  • Forecast, 2030 ~USD 2808.1 Million
  • Country China

China Infusion Pump Market Overview

Rapid Market Expansion :

China's infusion pump market is projected to grow from USD 1,722.1 million in 2025 to USD 2,808.1 million by 2030, representing a robust 10.3% CAGR, significantly outpacing the global growth rate of 7.4%.

Aging Population Dynamics :

China's rapidly aging demographic is a primary growth driver, with an increasing elderly population requiring chronic disease management and advanced infusion therapies in both hospital and outpatient settings.

Healthcare Modernization :

Accelerating healthcare infrastructure investments and government initiatives to upgrade medical device capabilities across tier-1, tier-2, and tier-3 cities are fueling demand for advanced infusion pump technologies.

Chronic Disease Prevalence :

Rising incidence of diabetes, cancer, cardiovascular diseases, and other chronic conditions in China is driving increased adoption of infusion pumps for precise drug delivery and patient management.

China Infusion Pump Market Dynamics

  • Government policies promoting domestic medical device manufacturing and hospital infrastructure upgrades are creating favorable conditions for market expansion across urban and emerging markets.
  • The increasing prevalence of chronic diseases combined with rising healthcare expenditure will continue to support robust demand for infusion pump solutions.
  • Additionally, technological advancements in smart infusion systems and integration with digital health platforms are expected to enhance market penetration and create new growth opportunities throughout the forecast period..

Related Ecosystem

Drug Delivery Devices

Top Technologies
  • Disposable Autoinjectors
  • Reusable Autoinjectors
  • Insulin Pumps
  • Pen Injectors
  • Transdermal Patches
Top Companies
  • Novo nordisk a/s
  • Becton, Dickinson and Company
  • Terumo Corporation
  • Medtronic plc
  • Nipro Corporation

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Abbott Laboratories
    • Stryker Corporation
    • Becton, Dickinson and Company
    • JOHNSON & JOHNSON

      Key Takeaways

      • China's infusion pump market will grow from USD 1,722.1M (2025) to USD 2,808.1M (2030) at a 10.3% CAGR.
      • China's aging demographics and chronic disease burden are primary drivers of infusion pump demand through 2030.
      • Government healthcare expansion and regulatory support are accelerating medical device adoption across China's hospital network.
      • China's infusion pump market growth rate significantly exceeds the global 7.4% CAGR, positioning it as a key Asia Pacific growth engine.

      Infusion Pump Market Report Scope

      Report Metric Details
      Base Year 2025
      Fastest Growing Segment SPECIALTY INFUSION PUMPS (Technology)
      Forecast Period 2025–2030
      Growth Rate CAGR of 7.4% from 2025 to 2030
      Largest Segment ACCESSORIES AND CONSUMABLES (Product)
      Market Size Base Year (Billions) ~USD 19.8 (2025)
      Revenue Forecast (Billions) ~USD 28.3 (2030)
      Segments Covered Product, Type, Technology, Mode, Mode Of Administration, End User, Application

      China Infusion Pump Market Report Segmentation

      7 segment dimensions are covered across the global market.

      By Product

      • Accessories And Consumables
      • Devices

      By Type

      • Ambulatory Infusion Pump Dedicated Disposables
      • Ambulatory Infusion Pumps
      • Cannulas
      • Chemotherapy Pumps
      • Dedicated Accessories And Consumables
      • Disposable Infusion Pumps
      • Enteral Infusion Pump Dedicated Disposables
      • Enteral Infusion Pumps
      • Implantable Infusion Pump Dedicated Disposables
      • Implantable Infusion Pumps
      • Infusion Catheters
      • Insulin Infusion Pump Dedicated Disposables
      • Insulin Infusion Pumps
      • Iv/Administration Sets
      • Needless Connectors
      • Non-Dedicated Accessories And Consumables
      • Other Non-Dedicated Accessories And Consumables
      • Patient Controlled Analgesia Infusion Pumps
      • Pca Pump Dedicated Disposables
      • Syringe Infusion Pump Dedicated Disposables
      • Syringe Infusion Pumps
      • Tubing And Extension Sets
      • Valves
      • Volumetric Infusion Pumps
      • Volumetric Pump Dedicated Disposables

      By Technology

      • Specialty Infusion Pumps
      • Traditional Infusion Pumps

      By Mode

      • Portable Infusion Pumps
      • Stationary Infusion Pumps

      By Mode Of Administration

      • Enteral
      • Epidural
      • Intrathecal
      • Intravenous
      • Subcutaneous

      By End User

      • Academic & Research Institutes
      • Ambulatory Care Settings
      • Home Care Settings
      • Hospital
      • Hospitals
      • Oncology Centers
      • Other End Users

      By Application

      • Analgesia/Pain Management
      • Chemotherapy/ Oncology
      • Chemotherapy/Oncology
      • Diabetes Management
      • Gastroenterology
      • Hematology
      • Other Applications
      • Pediatrics / Neonatology
      • Pediatrics/ Neonatology
      • Pediatrics/Neonatology

      Target Audience

      • Medical Device Manufacturers : Infusion pump manufacturers need China-specific market data to assess market potential, identify growth opportunities, and develop localized product strategies for this rapidly expanding healthcare market.
      • Healthcare Investors & PE Firms : Investment professionals require detailed China market analysis to evaluate portfolio opportunities, assess growth potential, and make informed capital allocation decisions in the medical device sector.
      • Hospital & Healthcare Administrators : Hospital procurement teams and healthcare facility managers need market insights to benchmark equipment costs, evaluate supplier options, and plan capital expenditures for infusion pump acquisitions.
      • Market Research & Strategy Consultants : Consulting firms advising healthcare and medical device clients require China-specific market data to support strategic recommendations, competitive analysis, and market entry planning initiatives.
      • Government & Policy Makers : Healthcare policy officials and government agencies need market intelligence to inform healthcare modernization strategies, medical device regulations, and resource allocation decisions for China's healthcare system.

      Key Companies in the China Infusion Pump Market

      CompanyHQOwnershipStrongest segments
      NOVO NORDISK A/SDenmarkPublic CompanyDiabetes care (insulin, GLP-1 injectables, related therapies),Obesity therapies (injectable and oral GLP-1 for weight management),Rare Disease (rare blood and endocrine disorders, HRT),
      CONSORT MEDICALUnited KingdomPrivate CompanyInhalation devices (MDIs, DPIs, respiratory platforms),Injectable and autoinjector devices,Nasal and other specialty delivery devices,
      CONVATECUnited KingdomPublic CompanyAdvanced Wound Care,Ostomy Care,Continence and Critical Care,
      FRESENIUS SE & CO KGAAGermanyPublic CompanyInjectable generics & IV fluids,Clinical nutrition (enteral & parenteral),Biopharmaceuticals & biosimilars,
      HENRY SCHEINUnited StatesPublic CompanyGlobal Distribution and Value-Added Services,Global Specialty Products,Global Technology,
      PFIZERIndiaPublic CompanyInternal medicine (cardio, respiratory, gastro, neuroscience, women’s health, pain, nutrition),Vaccines,Anti-infectives and injectables,
      ZOLL MEDICAL CORPORATIONUnited StatesPrivate CompanyDefibrillators and monitors (hospital and EMS),Automated external defibrillators (public access and basic EMS),LifeVest and wearable defibrillation,
      WILO SEGermanyPrivate CompanyBuilding Services Residential,Building Services Commercial,Original Equipment Manufacturers (OEM),
      ANGIODYNAMICS, INCUnited StatesPublic CompanyMed Device – Peripheral Access and Drainage (angiographic catheters, guidewires, drainage catheters, micropuncture kits, ports),Med Tech – Thrombus Management (AlphaVac, AngioVac, thrombolytic catheters),Med Tech – Atherectomy (Auryon Atherectomy System),
      MALLINCKRODT PLCIrelandPrivate CompanyAutoimmune and rare disease therapies,Immunotherapy and neonatal respiratory critical care,Analgesics,
      BECTON, DICKINSON AND COMPANYUnited StatesPublic CompanyMedical Essentials (syringes, needles, vascular access, sharps, basic disposables),Connected Care (infusion therapy, IV medication safety, pharmacy automation, informatics),BioPharma Systems (prefillable drug delivery systems),
      BAXTER INTERNATIONAL, INC.United StatesPublic CompanyMedical Products & Therapies,Healthcare Systems & Technologies,Pharmaceuticals,
      MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes),
      ICU MEDICAL, INC.United StatesPublic CompanyInfusion pumps and medication safety software,Vascular access and needlefree connectors,IV solutions and diluents,
      TERUMO CORPORATIONJapanPublic CompanyCardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company,
      NIPROJapanPublic CompanyDialysis products and services,Injection and infusion products, hospital and diabetic products,Pharmaceuticals (generic and kit products),
      AVANOS MEDICAL, INC.United StatesPublic CompanyDigestive health (Mic-Key, Corpak, NeoMed),Non-opioid surgical pain and recovery (ON-Q, ambIT, Game Ready),Interventional pain (COOLIEF, Trident, Esentec RFA),
      INSULET CORPORATIONUnited StatesPublic CompanyOmnipod 5 AID system,Omnipod DASH and legacy Omnipod systems,Drug-delivery pods (e.g., Neulasta Onpro),
      TANDEM DIABETES CARE, INC.United StatesPublic Companyt:slim X2 insulin pump systems,Tandem Mobi and automated insulin delivery systems,Cartridges and infusion sets,
      JMS CO., LTD.United StatesPublic CompanyU.S. Retail Coffee,U.S. Retail Frozen Handheld and Spreads,U.S. Retail Pet Foods,
      MOOG, INC.United StatesPublic CompanySpace and Defense,Military Aircraft,Commercial Aircraft,
      TELEFLEX INCORPORATEDUnited StatesPublic CompanyVascular access & emergency medicine (Arrow, EZ-IO, QuikClot),Interventional cardiology & peripheral (GuideLiner, Turnpike, MANTA, DCBs, stents),Surgical products (Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, Titan SGS),

      NOVO NORDISK A/S

      Novo Nordisk A/S is a Danish pharmaceutical company founded in 1923 with 67,900 employees. Operating as a public company, it is a major player in the global healthcare industry.

      CONSORT MEDICAL

      Consort Medical is a United Kingdom-based private company established in 1938 with 2,000 employees. The company operates in the medical device and pharmaceutical sectors.

      CONVATEC

      ConvaTec is a United Kingdom public company founded in 1978 specializing in medical devices and healthcare products. The company serves patients and healthcare providers globally.

      FRESENIUS SE & CO KGAA

      Fresenius SE & Co. KGaA is a German public company founded in 1912 with 177,783 employees. It is a leading global healthcare company providing dialysis, hospital care, and pharmaceutical products.

      HENRY SCHEIN

      Henry Schein is a United States-based public company founded in 1932 with 25,000 employees. The company is a major distributor of healthcare products and services to dental, medical, and veterinary markets.

      PFIZER

      Pfizer India is a public company established in 1950 with 1,244 employees. The company operates as part of the global Pfizer pharmaceutical organization in the Indian market.

      ZOLL MEDICAL CORPORATION

      ZOLL Medical Corporation is a United States-based private company founded in 1980 with 1,908 employees. The company specializes in emergency medical devices and software solutions.

      WILO SE

      Wilo SE is a German private company founded in 1872 with 8,442 employees. The company is a leading manufacturer of pumps and pump systems for heating, cooling, and water management.

      ANGIODYNAMICS, INC

      AngioDynamics, Inc. is a United States-based public company founded in 1988 with 632 employees. The company develops and manufactures minimally invasive medical devices for vascular access and oncology.

      MALLINCKRODT PLC

      Mallinckrodt PLC is an Ireland-based private company founded in 1867 with 2,687 employees. The company operates in the specialty pharmaceutical and medical device sectors.

      BECTON, DICKINSON AND COMPANY

      Becton, Dickinson and Company is a United States public company founded in 1897 with 72,000 employees. It is a global medical technology company providing medical devices, laboratory equipment, and diagnostic products.

      BAXTER INTERNATIONAL, INC.

      Baxter International, Inc. is a United States-based public company founded in 1931 with 37,500 employees. The company develops and manufactures healthcare products including IV solutions, infusion systems, and renal care products.

      MEDTRONIC

      Medtronic is a public company headquartered in Ireland and founded in 1949 with 95,000 employees. It is a global leader in medical technology providing devices and therapies for chronic diseases.

      ICU MEDICAL, INC.

      ICU Medical, Inc. is a United States-based public company founded in 1984 with 13,000 employees. The company manufactures and distributes medical devices for critical care and oncology applications.

      TERUMO CORPORATION

      Terumo Corporation is a Japanese public company founded in 1921 with 30,591 employees. The company is a global medical device manufacturer specializing in cardiovascular, transfusion, and cellular therapy products.

      NIPRO

      Nipro is a Japanese public company founded in 1947 with 38,593 employees. The company manufactures and distributes medical devices, pharmaceuticals, and healthcare products globally.

      AVANOS MEDICAL, INC.

      Avanos Medical, Inc. is a United States-based public company founded in 2014 with 2,287 employees. The company develops and markets medical devices for pain management and patient monitoring.

      INSULET CORPORATION

      Insulet Corporation is a United States public company founded in 2000 with 5,400 employees. The company manufactures and distributes insulin infusion pumps and continuous glucose monitoring systems.

      TANDEM DIABETES CARE, INC.

      Tandem Diabetes Care, Inc. is a United States-based public company founded in 2006 with 2,500 employees. The company develops and commercializes insulin delivery and diabetes management products.

      JMS CO., LTD.

      JMS Co., Ltd. is a United States-based public company founded in 1897 with 8,000 employees. The company operates in the medical device and healthcare products sector.

      MOOG, INC.

      Moog, Inc. is a United States-based public company founded in 1951 with 13,500 employees. The company manufactures precision motion and control products for aerospace, defense, and medical applications.

      TELEFLEX INCORPORATED

      Teleflex Incorporated is a United States public company founded in 1943 with 15,500 employees. The company designs and manufactures medical devices for critical care, surgery, and interventional procedures.

      Reasons to Buy this Report

      • Market Size & Growth Validation : Obtain precise market valuation data for China (USD 1,722.1M in 2025) with verified 10.3% CAGR projections through 2030, enabling accurate business planning and investment decisions specific to this high-growth market.
      • Competitive Positioning Intelligence : Understand China's market dynamics relative to global trends (7.4% CAGR) to identify competitive advantages, market gaps, and opportunities for product differentiation in this strategically important healthcare market.
      • Demographic & Disease Trend Analysis : Access detailed insights into China's aging population and chronic disease prevalence patterns driving infusion pump demand, enabling targeted marketing strategies and product development aligned with local healthcare needs.
      • Regulatory & Infrastructure Insights : Gain comprehensive understanding of China's healthcare modernization initiatives, government policies, and hospital infrastructure expansion plans that directly influence infusion pump adoption and market opportunities.
      • Strategic Market Entry Planning : Leverage China-specific market forecasts and growth drivers to develop informed market entry strategies, partnership opportunities, and distribution channel optimization for maximum ROI in this expanding market.

      Frequently asked questions

      What is the current size of China's infusion pump market?

      China's infusion pump market is valued at USD 1,722.1 million in 2025, making it a significant segment within Asia Pacific healthcare device markets.

      What is the projected market size for China's infusion pump market by 2030?

      China's infusion pump market is forecast to reach USD 2,808.1 million by 2030, representing substantial growth over the five-year period.

      What is the CAGR for China's infusion pump market?

      China's infusion pump market is expected to grow at a compound annual growth rate of 10.3% from 2025 to 2030.

      What factors are driving growth in China's infusion pump market?

      Key drivers include China's aging population, rising chronic disease prevalence, government healthcare investments, hospital infrastructure expansion, and supportive regulatory policies for medical device innovation.

      How does China's infusion pump market growth compare to global trends?

      China's 10.3% CAGR significantly outpaces the global infusion pump market CAGR of 7.4%, reflecting China's accelerated healthcare modernization and device adoption.

      RESEARCH METHODOLOGY

      This study extensively used both primary and secondary sources. The research involved studying various factors affecting the industry to identify segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

      Secondary Research

      This research study involved the usage of comprehensive secondary sources; directories; databases such as Bloomberg Business, Factiva, and Dun & Bradstreet; white papers; annual reports; company house documents; investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for an extensive, technical, market-oriented, and commercial study of the infusion pump market. It was also used to identify key players in the market and classify and segment the industry based on trends to the most detailed level. Additionally, significant developments related to market and technology perspectives were noted. A database of the primary industry leaders was also created using secondary research.

      Primary Research

      In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the infusion pump market. Primary sources from the demand side include healthcare professionals from hospitals, nursing care facilities, long-term health centers, and ambulatory surgery centers.

      A breakdown of the primary respondents is provided below:

      Infusion Pump Market

      Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.

      Note 2: Other designations include sales, marketing, and product managers.

      Note 3: Tiers are defined based on a company’s total revenue. As of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      The total size of the infusion pump market was determined after data triangulation from three approaches, as mentioned below. After each approach, the weighted average of the three approaches was taken based on the level of assumptions used in each approach.

      Infusion Pump Market

      Data Triangulation

      After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed wherever applicable to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

      Market Definition

      The infusion pump encompasses the global spectrum of advanced medical devices designed to deliver precise volumes of fluids—ranging from medications and nutrients to various therapeutic solutions—directly into a patient's vascular system. These devices are integral to contemporary healthcare, ensuring a meticulous administration of treatments that demand consistent dosing regimens, such as chemotherapy, pain management, insulin therapy, and hydration protocols. Infusion pumps are engineered for high programmability and versatility, capable of delivering both micro and macro volumes at continuous or intermittent rates based on clinical requirements. They can be categorized by functionality into several types: volumetric pumps, syringe pumps, patient-controlled analgesia (PCA) pumps, ambulatory infusion pumps, insulin pumps, and implantable infusion pumps. In contrast to traditional manual delivery methods, infusion pumps enhance accuracy, safety, and automation, making them indispensable in critical care environments and for effective chronic disease management. Their technological advancements facilitate complex infusion scenarios and improve patient outcomes through reliable dosing accuracy and reduced medication errors.

      Stakeholders

      • Medical device manufacturers and distributors
      • Infusion pump manufacturers
      • Infusion pump and related instrument manufacturing companies
      • Suppliers and distributors of infusion pumps
      • Hospitals and ambulatory surgery centers
      • Clinics
      • Home healthcare agencies
      • Research and consulting firms
      • Contract manufacturing organizations
      • Venture capitalists

      Report Objectives

      • To define, describe, segment, and forecast the infusion pump market by type, mode of administration, application, end user, and region
      • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
      • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall infusion pump market
      • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
      • To forecast the size of the infusion pump market in five main regions (along with their respective key countries), namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
      • To profile the key players in the infusion pump market and comprehensively analyze their core competencies and market shares
      • To track and analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships

       

      Get the Full Infusion Pump Market Report

      Full forecast, segment splits, and company analysis for all Infusion Pump Market.

      Download Sample Pages Buy Report

      METHODOLOGY

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      Cite this Research
      DMCA.com Protection Status